Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban Safety in Indian TKR/THR Patients
NCT01884337Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in venous thromboembolism (VTE), sponsored by Bristol Myers Squibb. Started Mar 2015; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01884337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01884337.